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. Thus, by separate methods in neural and nondriven simply by a propensity for self-association. To identify mechanisms that would not have been clearly neural cells, both nuclear and cytoplasmic inclusions produced strong FRET, whereas diffusely distributed predicted from prior knowledge, we chose to investigate the cellular regulation of aggregate formation using a protein did not. high-throughput approach. Here we describe the development of this method, its use as a screening tool to
Detection of FRET Signal in Cell Monolayers identify a potential therapeutic compound, and new in-
Using Emission Scans in a Fluorescence sights into a pathway that can regulate polyglutamine Plate Reader aggregation.
To monitor polyglutamine protein aggregation based on FRET in transfected cell monolayers, we created an assay system using a monochrometer-based fluoresResults cence plate reader (FPR). We used HEK293 cells for their ease of transfection and high protein expression Aggregated Polyglutamine Proteins Produce FRET when Fused to Fluorescent Proteins levels and our ability to induce a high degree of nuclear aggregation. We performed emission scans using exciTo develop a screening assay, we began with an aminoterminal 127 amino acid fragment of AR containing either tation at either 435 nm or 485 nm, and controls of CFP and YFP alone to calculate CFP bleedthrough into the 25 glutamine repeats (ARN127(25)) or a pathologic expanded tract of 65 repeats (ARN127(65)). These poly-YFP spectrum, and crossover activation of YFP by 435 nm excitation. These scans detected a robust FRET peptides were fused at their carboxyl termini either to CFP or YFP coding sequences ( Figure 1A (htt(72)CFP/YFP) ( Figure 3B ), demonstrating that its efmost had negligible effects on polyglutamine aggregation (0%-30% reduction), attributable primarily to wellfects were not limited to a single polyglutamine protein.
Next, we tested this method as a high-throughput well variation in the assay. In contrast, a small number of compounds showed more robust effects of Ͼ50% system by initiating a screen of 2800 biologically active compounds, comprising the Annotated Compound Lireduction in aggregation ( Figure 3E ). Detailed secondary screens will be required to characterize these hits; howbrary (ACL) (Root et al., 2003) . This required small adaptations of our protocol to include internal controls and ever, these results demonstrate the power of this screening method to identify inhibitors across a broad interassay standardization. Polyglutamine aggregation may be reduced by several means, including decreased spectrum of compounds. ( Figure 4A ). While modest, these results were consistent with the pharmacologic effects of Y-27632 and raised Compounds were assayed in duplicate. We found that Advantages of this approach are numerous. Because knowledge, however, this is the first use of such technolthe assay depends on particular molecular eventsogy to study intracellular protein interactions on a quanmisfolding and aggregation-it is likely that hits will be titative, high-throughput basis, entirely distinct from mirelatively specific to this process. In contrast to microscroscopy. We demonstrated the ability of this approach copy-based methods that rely on analysis of macromoto quantitatively and rapidly screen the ACL (approxilecular aggregation, this FRET-based method in theory mately 2800 compounds) and are currently analyzing the will produce signal even if aggregates consist of oligomeric structures that escape standard detection. Seccandidates. In an initial screen, however, we examined a 
